Evolutionary relationships between Saccharomyces cerevisiae and other fungal species as determined from genome comparisons.

Departamento de Ciencias Medicas Basicas, Facultad de Medicina, Universitat de Lleida, Montserrat Roig 2, 25008 Lleida, Spain.
Revista Iberoamericana de Micología (Impact Factor: 0.97). 01/2006; 22(4):217-22. DOI: 10.1016/S1130-1406(05)70046-2
Source: PubMed

ABSTRACT The increasing number of fungal genomes whose sequence has been completed permits their comparison both at the nucleotide and protein levels. The information thus obtained improves our knowledge on evolutionary relationships between fungi. Comparison of the Saccharomyces cerevisiae genome with other Hemiascomycetes genomes confirms that a whole-genome duplication occurred before the diversification between Candida glabrata and the Saccharomyces sensu stricto species and after separation from the branch leading to the other Hemiascomycetes. Duplication was followed by individual gene losses and rearrangements affecting extensive DNA regions. Although S. cerevisiae and C. glabrata are two closely related yeast species at an evolutionary scale, their different habitats and life styles correlate with specific gene differences and with more extensive gene loses having occurred in the parasitic C. glabrata. At a closer evolutive scale, diversification among the sensu stricto species began with nucleotide changes at the intergenic regions affecting sequences that are not relevant for gene regulation, together with more extensive genome rearrangements involving transposons and telomeric regions. One important characteristic of fungal genomes that is shared with other eukaryotes is the fusion of gene sequences coding for separate protein modules into a single open reading frame. This allows diversification of protein functions while saving gene information.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Infections by Candida albicans and related fungal pathogens pose a serious health problem for immune compromised patients. Azole drugs, the most common agents used to combat infections, target the sterol biosynthetic pathway. Adaptation to azole therapy develops as drug stressed cells compensate by up-regulating several genes in the pathway, a process mediated in part by the Upc2 transcription factor. We have implemented a cell-based high throughput screen to identify small molecule inhibitors of Upc2-dependent induction of sterol gene expression in response to azole drug treatment. The assay is designed to identify not only Upc2 DNA binding inhibitors, but also compounds impeding the activation of gene expression by Upc2. An AlphaScreen® assay was developed to determine if the compounds identified interact directly with Upc2 and inhibit DNA binding. Three compounds identified by the cell-based assay inhibited Upc2 protein level and UPC2-LacZ gene expression in response to a block in sterol biosynthesis. The compounds were growth inhibitory and attenuated antifungal-induced sterol gene expression in vivo. They did so by reducing the level of Upc2 protein and Upc2 DNA binding in the presence of drug. The mechanism by which the compounds restrict Upc2 DNA binding is not through a direct interaction, as demonstrated by a lack of DNA binding inhibitory activity using the AlphaScreen® assay. Rather, they likely inhibit a novel pathway activating Upc2 in response to a block in sterol biosynthesis. We suggest the compounds identified represent potential precursors for the synthesis of novel antifungal drugs.
    Antimicrobial Agents and Chemotherapy 10/2013; 58(1). DOI:10.1128/AAC.01677-13 · 4.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cryptococcus neoformans, a pathogenic, yeast-like fungus, typically forms biofilms on medical devices that prevents the efficient penetration of antifungal drugs. As quorum sensing (QS)-related chemoreceptors play a crucial role in the pathogenesis of Cryptococcus neoformans particularly in biofilm formation, studying them would enable a clearer understanding on the host-pathogen interaction. However, information regarding C. neoformans QS-related chemoreceptors such as the encoding DNA sequences, protein structures and the binding ligands remain unknown till today. Here, we provide information to facilitate researchers to comprehend the basic views on gene homology and its various applications in the identification of novel chemoreceptors in microorganism especially the novel QS-related chemoreceptors for future use.
    AFRICAN JOURNAL OF BIOTECHNOLOGY 06/2012; 11(46). DOI:10.5897/AJB11.042 · 0.57 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Invasive candidiasis is associated with high mortality in immunocompromised and hospitalized patients. Candida albicans is the main pathological agent followed by Candida glabrata, Candida krusei, Candida parapsilosis, and Candida tropicalis. These pathogens colonize different host tissues in humans as they are able to neutralize the reactive species generated from nitrogen and oxygen during the respiratory burst. Among the enzymatic mechanisms that Candida species have developed to protect against free radicals are enzymes with antioxidant and immunodominant functions such as flavohemoglobins, catalases, superoxide dismutases, glutathione reductases, thioredoxins, peroxidases, heat-shock proteins, and enolases. These mechanisms are under transcriptional regulation by factors such as Cta4p, Cwt1p, Yap1p, Skn7p, Msn2p, and Msn4p. However, even though it has been proposed that all Candida species have similar enzymatic systems, it has been observed that they respond differentially to various types of stress. These differential responses may explain the colonization of different organs by each species. Here, we review the enzymatic mechanisms developed by C. albicans and C. glabrata species in response to oxidative and nitrosative stresses. Lack of experimental information for other pathogenic species limits a comparative approach among different organisms.
    Current Microbiology 07/2014; 69(5). DOI:10.1007/s00284-014-0651-3 · 1.36 Impact Factor


Available from